Filling the need for trusted information on national health issues

New York Times’ ‘Room For Debate’ Feature Discusses PrEP HIV Prevention Strategy

New York Times: Is a Pill Enough to Fight HIV?
“New federal guidelines urge gay men and others who have unprotected sex to take a daily dose of the drug Truvada, a regimen called pre-exposure prophylaxis (PrEP), to curb HIV infections and AIDS. Is promoting the use of the antiviral drug a good public health strategy, or will it encourage more to have unprotected sex?” The newspaper features opinion pieces from Michael Weinstein, president of the AIDS Healthcare Foundation; Renato Barucco, head of the Transgender Family Program at Community Healthcare Network in New York City; Larry Kramer, a gay rights advocate and playwright; Peter Acworth, founder and chief executive of; and Kenneth Mayer, a professor at Harvard Medical School, director of HIV prevention research at Beth Israel Deaconess Medical Center in Boston, and founder and medical research director of the Fenway Institute (6/17).